» Articles » PMID: 36419963

Obstetric Complications in Mothers with ADHD

Overview
Date 2022 Nov 24
PMID 36419963
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is currently limited research on the intersection of pregnancy and ADHD and the unique pregnancy risk factors for mothers with an ADHD diagnosis. With an increased population of patients with ADHD in the recent decades and an increase in ADHD medication use during pregnancy it is important to consider what unique risks mothers with ADHD face during the perinatal period.

Objective: Investigate a variety of outcomes in maternal ADHD.

Methods: We identified female patients with a diagnosis of pregnancy and ADHD diagnosis. We also further separated the ADHD cohort for separate sub-analyses based on medication type. Odds ratios and relative risk were calculated from outcome incidence within each cohort. Cohorts were balanced on age, sex, and race.

Results: We identified 45,737 pregnant females with ADHD. We matched these patients to pregnant females without ADHD, for a total of 42,916 pairs. Compared to the group without ADHD, mothers with ADHD had higher rates of every outcome except for HPV infection, which was statistically insignificant ( = 0.768). The odds ratios ranged from 1.08 for anemia complicating pregnancy to 2.63 for depressive episodes. Most outcomes were between 1.2 and 1.8 times more likely to occur in the cohort with ADHD.

Conclusion: This study presents substantial advancements in our knowledge of pregnancy-related ADHD care. Armed with an increased awareness of these potential complications and their relationship with ADHD, obstetricians, psychiatrists, and providers of all specialties may be able to reduce the rate of complications within this specific patient population.

Citing Articles

Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review.

De Hondt L, Cosemans C, Plusquin M, Mangelings D, Van Eeckhaut A, Tommelein E Front Public Health. 2024; 12:1437328.

PMID: 39171321 PMC: 11335559. DOI: 10.3389/fpubh.2024.1437328.


The association between attention deficit hyperactivity disorder and pregnancy, delivery and neonatal outcomes-an evaluation of a population database.

Amikam U, Badeghiesh A, Baghlaf H, Brown R, Dahan M BMC Pregnancy Childbirth. 2024; 24(1):364.

PMID: 38750437 PMC: 11095018. DOI: 10.1186/s12884-024-06561-5.


Fracture rates by medication type in attention-deficit/hyperactive disorder.

Sidrak J, Blaakman S, Hale E Front Surg. 2023; 10:973266.

PMID: 36874450 PMC: 9975348. DOI: 10.3389/fsurg.2023.973266.


Baseball injuries in adolescent athletes with ADHD.

Feldkamp J, Stevens A, Blaakman S, Hale E Front Sports Act Living. 2023; 4:1032558.

PMID: 36699984 PMC: 9870624. DOI: 10.3389/fspor.2022.1032558.

References
1.
Leong C, Raymond C, Chateau D, Dahl M, Alessi-Severini S, Falk J . Psychotropic Drug Use before, during, and after Pregnancy: A Population-Based Study in a Canadian Cohort (2001-2013). Can J Psychiatry. 2017; 62(8):543-550. PMC: 5546669. DOI: 10.1177/0706743717711168. View

2.
Rose S, Hathcock M, White W, Borowski K, Rivera-Chiauzzi E . Amphetamine-Dextroamphetamine and Pregnancy: Neonatal Outcomes After Prenatal Prescription Mixed Amphetamine Exposure. J Atten Disord. 2020; 25(9):1295-1301. DOI: 10.1177/1087054719896857. View

3.
Owens E, Hinshaw S . Adolescent Mediators of Unplanned Pregnancy among Women with and without Childhood ADHD. J Clin Child Adolesc Psychol. 2019; 49(2):229-238. PMC: 6661209. DOI: 10.1080/15374416.2018.1547970. View

4.
Lemelin M, Sheehy O, Zhao J, Berard A . Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis. Eur Neuropsychopharmacol. 2021; 44:66-78. DOI: 10.1016/j.euroneuro.2021.01.003. View

5.
Backes C, Markham K, Moorehead P, Cordero L, Nankervis C, Giannone P . Maternal preeclampsia and neonatal outcomes. J Pregnancy. 2011; 2011:214365. PMC: 3087144. DOI: 10.1155/2011/214365. View